Curing Blindness
Elon Musk’s Neuralink achieved a significant milestone last week in its pursuit to restore vision to those who have lost it. The neurotechnology company, founded by Musk, announced on X (formerly Twitter) that it had been granted “Breakthrough Device Designation from the FDA” for its innovative Blindsight device.
Musk described the Blindsight device as capable of allowing even individuals who have lost both their eyes and optic nerves to regain sight. “As long as the visual cortex is intact, the device will even enable those who have been blind since birth to see for the first time,” Musk wrote on X. Initially, the vision provided by Blindsight will be low-resolution, Musk noted, comparing it to “Atari graphics.” However, he highlighted its potential to improve dramatically over time. While this isn’t the first time Musk has suggested that Blindsight might exceed normal vision, some experts remain skeptical. Research from the University of Washington cautioned that without significant technological breakthroughs, the vision provided by Blindsight and similar devices is likely to remain limited and imperfect.
Earlier this year, Neuralink made headlines after successfully implanting a brain chip into Noland Arbaugh, a paralyzed man. Following the procedure, Arbaugh was able to control computers and play online games using only his mind.
The FDA’s Breakthrough Devices Program aims to expedite the development and approval process for devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions.